Researchers Develop Structural Blueprint of Nanoparticles to Target White Blood Cells Responsible for Acute Lung Inflammation

The COVID-19 pandemic highlighted the devastating impact of acute lung inflammation (ALI), which is part of the acute respiratory distress syndrome (ARDS) that is the dominant cause of death in COVID-19.